PYXS
USDPyxis Oncology Inc. Common Stock
$3.900+0.090 (2.362%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$3.810
High
$4.169
Low
$3.600
Volume
0.79M
Company Fundamentals
Market Cap
242.8M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.76M
Exchange
NMS
Currency
USD
52-Week Range
Low $0.833Current $3.900High $5.39
Related News
Analyst Upgrades
Guggenheim Maintains Buy on Pyxis Oncology, Raises Price Target to $7
Guggenheim analyst Brad Canino maintains Pyxis Oncology with a Buy and raises the price target from $5 to $7.
View more
GlobeNewswire
Pyxis Oncology to Participate in Upcoming Investor Conferences
BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (NASDAQ:PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that management will
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.